CA
NZ
UK
AU
IND
US
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) announced updates related to its Founded Entity, Vor Bio (Nasdaq: VOR), following two major financial transactions. Vor Bio has entered an exclusive global license agreement with RemeGen Co., Ltd. (HKEX: 9995, SHA: 688331), excluding China, Hong Kong, …
Evotec SE (Frankfurt Stock Exchange: EVT; Nasdaq: EVO) has announced its participation in the NURTuRE-AKI consortium, a longitudinal research initiative focused on acute kidney injury (AKI) and its progression to chronic kidney disease (CKD). The study targets both adult and pediatric cardiac surgery patients …
InspireMD, Inc. (Nasdaq: NSPR), a medical technology company focused on stroke prevention, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for its CGuard Prime Carotid Stent System. The approval allows the commercial launch of the device in the U.S. …
argenx SE (Euronext & Nasdaq: ARGX)is a biopharmaceutical company focused on the development of antibody-based treatments for severe autoimmune diseases. Through collaborations with academic researchers, argenx aims to build a portfolio of immune-mediated therapies. The company is advancing its FcRn blocker, efgartigimod, across multiple …
GH Research PLC (Nasdaq: GHRS),a clinical-stage biopharmaceutical company focused on depression treatments, announced that it has submitted its full response to the U.S. Food and Drug Administration (FDA) concerning the clinical hold placed on its Investigational New Drug (IND) application for GH001. The company …
Roth Capital has reaffirmed its "Buy" rating on shares ofVerona Pharma PLC American Depositary Share(NASDAQ: VRNA) while raising its price target to USD116 from the previously assigned USD92. The revised target was noted in a research report issued Wednesday morning, as reported by Benzinga.
AbbVie, Inc. (NYSE: ABBV)is a U.S.-based biopharmaceutical company headquartered in North Chicago, Illinois. The firm was spun off from Abbott Laboratories in 2013 and focuses on research and development across several therapeutic areas, including immunology, oncology, neuroscience, and eye care. AbbVie markets several major …
Moleculin Biotech, Inc. (NASDAQ: MBRX)is a Houston-based clinical-stage pharmaceutical company focused on the development of oncology therapeutics. Its lead candidates include Annamycin (in development for AML and other cancers), WP1066 (targeting glioblastoma and brain metastases), and other molecules designed to exploit tumor-specific pathways. The …
Axsome Therapeutics Inc. (NASDAQ: AXSM) experienced a slight drop in its share price this week, following a downgrade by Royal Bank of Canada. The firm adjusted its rating fromOutperformtoMarket Perform, citing a reassessment of valuation metrics and future growth assumptions.
Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF), a UK-based biotechnology company with research operations in Belgium, has provided a mid-year update on its gene therapy pipeline focused on aging and age-related diseases. The company, which holds exclusive rights to SIRT6 gene variants associated with longevity, has reported …
Please wait processing your request...